Summary. 1, 24, tamin D binding protein were determined in 87 serum samples from 46 Type 1 (insuli n-dependent) diabetic children and adolescents at the various stages of puberty. The results were compared with data similarly obtained from healthy pubertal children. The diabetic patients had lower mean 1,25-dihydroxyvitamin D concentrations (p<0.05) and higher molar ratios of 24,25-dihydroxyvitamin D to 25-hydroxyvitamin D (p< 0.05) than their healthy counter parts. In contrast to the reference group, the diabetic patients failed to attain the increase in 1,25-dihydroxyvitamin D normally seen during the pubertal stages of maximal growth velocity. The mean plasma levels of vitamin-D binding protein did not differ between the two groups, and a calculated 'free' 1,25-dihydroxyvitamin D value followed a pattern similar to that of total 1,25-dihydroxyvitamin D throughout puberty for both groups. The results suggest that the regulatory mechanisms of the vitamin D endocrine system are altered in diabetic children at puberty, resulting in a relative decrease in 1,25-dihydroxyvitamin D plasma concentration and increased 24,25-dihydroxyvitamin D levels. A possible connection between diabetes and osteopenia has been shown [1-3], but the exact metabolic cause has not been determined. Experiments in rats and observations in diabetic patients have suggested that an altered vitamin D metabolism may be involved in the pathogenesis of reduced bone mass [4-111. Puberty represents a period of rapid skeletal growth, and we have previously shown that the growth spurt is associated with increased serum concentrations of 1,25-dihydroxyvitamin D (I,25-OH)2D) and decreased relative levels of 24,25-dihydroxyvitamin D (24,25-(OH)2D) [12] . The purpose of the present study was to determine whether the vitamin D metabolism of diabetic patients differs from that of their healthy counterparts during puberty.
A possible connection between diabetes and osteopenia has been shown [1] [2] [3] , but the exact metabolic cause has not been determined. Experiments in rats and observations in diabetic patients have suggested that an altered vitamin D metabolism may be involved in the pathogenesis of reduced bone mass [4-111. Puberty represents a period of rapid skeletal growth, and we have previously shown that the growth spurt is associated with increased serum concentrations of 1,25-dihydroxyvitamin D (I,25-OH)2D) and decreased relative levels of 24,25-dihydroxyvitamin D (24,25-(OH)2D) [12] . The purpose of the present study was to determine whether the vitamin D metabolism of diabetic patients differs from that of their healthy counterparts during puberty.
Subjects
Eighty-seven plasma samples from 46 Type 1 (insulin-dependent) diabetic children and adolescents (see Table 1 ) were collected. The samples were collected at different stages of puberty and no patient appears more than once at each pubertal stage. The samples were obtained throughout the year by simple venepuncture between 10 and 12 h. Pubertal stage was graded from P1 (prepubertal) to P5 (adult) according to pubic hair development in boys, and breast development in girls [13] . None had experienced episodes of diabetic ketoacidosis recently. Individuals with endocrine disorders other than diabetes, hepatic, renal or gastrointestinal disease, and patients on anticonvulsant or glucocorticoid therapy were excluded from the study. One hundred and ninety-one healthy children and adolescents aged 8-18 years of age, and similarly distributed throughout the various stages of puberty, served as a reference population. Details regarding this group have been published previously [12] .
By our standards 25-hydroxyvitamin D (25-OHD) concentrations < 20 nmol/1 are considered indicative of vitamin D deficiency [141. Three diabetic children had 25-OHD values in this range and were excluded from the study, since it was considered likely that the vitamin D deficiency could affect the synthesis of the dihydroxyvitamin D metabolites.
Methods
Vitamin D metabolites were extracted from plasma samples (2 ml) with diethyl ether, and isolated and purified by high performance liquid chromatography employing silicic acid columns [15] . No 25-OHD2 was detected in the plasma samples, as judged by ultraviolet-absorption of the eluates [16] (detection limits, 1.25 nmol/1), and only the vitamin D 3 metabolite fractions were collected and assessed quantitatively. These metabolites were determined by competitive protein-binding assays using human serum (25-OHD and 24,25-(OH)zD) and chick duodenal cytosol (l,25-(OH)zD) as binding proteins [16] . The intra-and interassay coefficients of variation and detection limits (based on 2 ml extracted plasma) for the determination of the metabolites were: 25-OHD: 6.3%, 8.5% and 0.8nmol/1; 1,25-(OH)zD: 9.7%, 12.1% and 7pmol/1; and 24,25-(OH)zD: 7%, 9.7% and 0.08 nmol/1. The 24,25-(OH)2D concentrations were expressed as molar ratios to the corresponding 25-OHD concentrations, since the plasma concentration of 24,25-(OH)2D is linearly correlated to the concentration of its precursor [12, 17, 18] , and these ratios therefore give a better reflection of the relative synthesis of 24,25-(OH)2D than absolute concentrations [12] .
The vitamin D binding protein (DBP) was measured by quantitative rocket immunoelectrophoresis using rabbit immunoglobulin to human gc-globulin (DaK~, Copenhagen, Denmark). The concentration of 'free' 1,25-(OH)zD was calculated as the ratio between the molar concentrations of total 1,25-(OH)zD and DBP [19] .
Calcium was determined by the o-cresolphthalein complexone method [20] , phosphate by the malachite green/molybdate method [211 and alkaline phosphatase by a manual colorimetric method [21] . Results are expressed as mean • gEM with ranges in parentheses Due to lack of serum, only a limited number of subjects had concentrations of calcium, phosphate, alkaline phosphatase and vitamin-D binding protein determined ( 
Results
Diabetic boys and girls had significantly lower 1,25-(OH)2D concentrations and higher relative levels of 24,25-(OH)zD, expressed as the molar ratio of 24,25-(OH)2D to 25-OHD, than the healthy controls during most stages of puberty (Fig. 1) . The reciprocal increase in 1,25-(OH)2D and decrease in 24,25-(OH)2D to 25-OHD ratio observed in normal puberty was lacking for the diabetic children (Fig. 1) . The serum levels of 24,25-(OH)2D and 25-OHD were linearly related in both the diabetic and reference children with regression lines 24,25-(OH)2D=0. 028 25-OHD+ 1.1 (r =0.50, p<0.0005), and 24,25-(OH)2D = 0.052 25-OHD-1.4 (r = 0.84, p< 0.0005) respectively. The diabetic children had a lower mean 25-OHD concentration than the ref- Results are presented as mean+ SEM. NS=non significant. Measurements of calcium and phosphate were carried out in randomized subgroups erence children (Table 2 ). There was no correlation between the 25-OHD and 1,25-(OH)zD concentrations in either group. The mean concentration of DBP did not differ between the two groups (Fig. 2) , and the calculated 'free' fraction of 1,25-(OH)2D was significantly lower in the diabetic children. The diabetic children had a lower mean serum calcium and higher phosphate concentration than the healthy control group ( Table 2) . None of these parameters changed significantly with the stages of puberty. The mean alkaline phosphatase value was higher in the diabetic than in the reference group in early puberty for the boys, and in late puberty for the girls (Fig. 3) . There was no significant relationship between any of the vitamin D metabolites and the remaining biochemical parameters. Neither were there any correlations between insulin dose, duration of diabetes or 24 h-urinary glucose excretion, on the one hand, and vitamin D metabolites on the other hand.
Discussion
We have shown previously that the shape of curves showing changes in the mean plasma concentrations of 1,25-(OH)2D throughout puberty are reminiscent of those of growth velocity curves in puberty [12] . The adolescent growth-spurt of a typical girl occurs 2 years earlier than that of a boy, and reaches a peak at about age 12.0 in girls and 14.0 years in boys [23] . Since puberty is frequently delayed in Type 1 diabetic children [24] , the serum concentrations of vitamin D metabolites were related to the stage of pubic hair development in boys and breast development in girls, rather than to chronological age. Unlike growth, the first development of sexual maturation does not occur 2 years earlier in girls than boys, but rather takes place about 6 months earlier [23] . In the average girl, the peak height velocity is reached soon after breast development stage 2, whereas in boys, it is usually not attained before pubic hair stages 3-4 [23] . Experimental animal data have shown that the synthesis of a,25-(OH)2D and 24,25-(OH)2D are normally regulated in a reciprocal fashion, so that 1,25-(OHhD production is stimulated and 24,25-(OH)zD synthesis suppressed in conditions of increased requirement of calcium and phosphate, while the reverse situation occurs in mineral replete subjects [25] . The high 1,25-(OH)2D and low 24,25-(OH)2D/25-OHD ratios observed in normal pubertal growth [12] and similar conditions of increased bone mineral requirement such as the rapid growth of infancy [26] , suggest that the same model applies to humans.
As in the present study, other authors have found decreased a,25-(OH)2D and increased 24,25-(OH)2D concentrations in young Type I diabetic subjects [10, 11] . This study extends these observations, by showing that diabetic children also fail to attain the reciprocal increase in 1,25-(OH)2D and decrease in relative 24,25-(OH)2D levels normally seen during puberty when the skeletal growth is particularly rapid. The differences in 1,25-(OH)2D levels were not due to variation in DBP concentrations.
The diabetic children had a lower mean 25-OHD than the control group, but it is unlikely that the difference in 1,25-(OH)2D levels was related to this factor, since 1,25-(OH)2D synthesis appears to be uninhibited so long as the 25-OHD level is within the normal range [26] . The lack of correlation between 25-OHD and 1,25-(OH)2D observed in the present study further supports this assumption.
All patients had normal renal function, and therefore the lower 1,25-(OH)2D levels, and lower plasma calcium and higher plasma phosphate levels, can not be explained by impaired renal function. Insulin has been shown to have a direct effect on renal 25-hydroxy D3-l-alpha hydroxlase, and insulin deficiency could be a possible explanation for the observed differences in vitamin D metabolism.
The primary function of the vitamin D endocrine system appears to be the maintenance of calcium and phosphate homeostasis in the extracellular fluid. Mobilization of bone minerals to the extracellular fluid or a failure to incorporate calcium and phosphate in bone, as has been suggested by Levin et al. [1] to be the pa-thogenetic factor of diabetic osteopenia, would tend to increase the supply of calcium and phosphate to the extracellular fluid. These suggestions are in agreement with the finding of increased urinary excretion of calcium and phosphate in diabetic patients [8, 27] . Increased mobilization or decreased deposition of bone minerals might also explain the observed decrease in the serum level of parathyroid hormone in children and adolescents with Type 1 diabetes [11, 27] . According to the present concept of vitamin D synthesis and regulation, alterations in calcium homeostasis would tend to suppress the formation of 1,25-(OH)2D and stimulate 24,25-(OH)2D synthesis.
